type
interferon
ifn
protect
host
virus
engag
cognat
receptor
consist
chain
induc
downstream
signal
gene
express
howev
inflammatori
stimuli
trigger
ubiquitin
downregul
therebi
attenu
ifn
effect
vitro
signific
paradox
regul
unknown
present
result
demonstr
inabl
stimul
ubiquitin
sa
knockin
mice
render
highli
suscept
numer
inflammatori
syndrom
includ
acut
chronic
pancreat
autoimmun
toxic
hepat
sa
mice
bone
marrowreceiv
wild
type
anim
display
persist
immun
infiltr
inflam
tissu
extens
damag
grave
inadequ
tissu
regener
pharmacolog
stimul
ubiquitin
protect
toxic
hepat
fulmin
gener
inflamm
wild
type
sa
mice
result
suggest
endogen
mechan
trigger
ubiquitin
limit
inflammationinduc
tissu
damag
purpos
mimick
therapeut
benefit
inflamm
evolv
adapt
process
combin
counteract
element
tissu
destruct
versu
heal
limit
eventu
elimin
harm
effect
irrit
infecti
agent
initi
stage
inflamm
exacerb
tissu
damag
often
follow
subsequ
regenerationrepair
tissu
restor
function
medzhitov
failur
progress
later
stage
contribut
develop
chronic
patholog
condit
associ
numer
human
diseas
includ
pancreat
hepat
arthriti
neurodegen
syndrom
despit
enorm
medic
signific
persist
inflamm
mechan
restrain
tissu
damag
ensur
transit
restor
phase
larg
remain
understood
nathan
ding
chronic
viral
infect
grow
tumor
among
known
induc
persist
inflamm
li
et
al
cytokin
belong
famili
type
interferon
ifn
protect
host
virus
tumor
stark
et
al
ifn
act
cell
engag
cell
surfaceloc
cognat
receptor
form
chain
subsequ
stimul
signal
transduct
cascad
includ
activ
janu
kinas
jak
signal
transduct
activ
transcript
protein
uze
et
al
latter
interact
form
specif
transcript
activ
complex
capabl
induc
plethora
ifnstimul
protein
act
concert
mediat
antivir
antitumorigen
immunomodulatori
effect
ifn
effect
underli
use
pharmacolog
formul
ifn
treatment
viral
infect
cancer
multipl
sclerosi
stark
et
al
platania
stark
darnel
howev
benefit
ifn
action
host
offset
tissu
toxic
elicit
cytokin
trinchieri
importantli
antivir
effect
ifn
action
could
achiev
low
concentr
higher
dose
requir
achiev
antiprolif
antisurviv
effect
ifn
tumor
benign
cell
jaitin
et
al
furthermor
toxic
effect
ifn
correl
affin
jaitin
et
al
kali
et
al
thoma
et
al
de
weerd
et
al
requir
much
higher
cell
surfac
densiti
receptor
moraga
et
al
levin
et
al
piehler
et
al
cell
surfac
level
ifn
receptor
ensu
sensit
cell
ifn
neg
regul
ubiquitin
endocytosi
degrad
facilit
btrcp
ubiquitin
ligas
kumar
et
al
kumar
et
al
abil
btrcp
interact
ubiquitin
protein
requir
phosphoryl
specif
serin
residu
mous
human
receptor
within
conserv
degron
motif
locat
intracellular
domain
kumar
et
al
kumar
et
al
phosphoryl
trigger
ifn
kumar
et
al
marijanov
et
al
jakmedi
activ
protein
kinas
attenu
ifn
signal
ubiquitinationdriven
downregul
degrad
zheng
et
al
c
importantli
phosphoryl
induc
ligandunrel
stimuli
altogeth
desensit
cell
ifn
review
fuch
exampl
vascular
endotheli
growth
factor
vegf
trigger
ubiquitin
downregul
blunt
cellular
respons
ifn
zheng
et
al
stimuli
capabl
ifnindepend
phosphoryl
util
differ
pathway
liu
et
al
liu
et
al
involv
phosphoryl
casein
kinas
liu
et
al
amplifi
adjac
prime
phosphoryl
bhattacharya
et
al
mediat
stressactiv
protein
kinas
bhattacharya
et
al
stimuli
includ
inflammatori
cytokin
tumor
necrosi
factora
tnfa
huangfu
et
al
bacteri
lipopolysaccharid
lp
inflammatori
stimuli
trigger
phosphoryl
ubiquitin
degrad
result
larg
depriv
cell
abil
respond
futur
encount
ifn
vitro
zheng
et
al
huangfu
et
al
regul
occur
vivo
might
pose
medic
problem
reduc
efficaci
pharmaceut
ifn
inflam
tissu
furthermor
exist
mechan
somewhat
counterintuit
host
defens
may
limit
antivir
antitumorigen
benefit
endogen
produc
ifn
within
region
inflamm
henc
sought
investig
manifest
biolog
signific
inflammationinduc
ubiquitin
downregul
vivo
initi
focus
role
ifn
signal
stabil
develop
acut
pancreat
deadli
diseas
affect
million
peopl
worldwid
review
pandol
wherea
etiolog
diseas
complex
common
pathogenet
mechan
includ
foodalcoholinduc
pancreat
hyperstimul
pancreat
duct
obstruct
lead
increas
pancreat
duct
pressur
reflux
activ
trypsin
result
trypsin
proteolyt
enzym
becom
activ
within
pancreat
acinar
cell
result
autolysi
induct
local
inflamm
review
pandol
reichert
rustgi
intriguingli
pancreat
induc
mani
pathway
known
downregul
vegf
kuehn
et
al
unfold
protein
respons
kubisch
logsdon
pathogen
recognit
receptor
pastor
et
al
li
et
al
furthermor
number
report
case
iatrogen
pancreat
attribut
ifnbas
drug
trivedi
pitchumoni
ifninduc
pancreat
inflamm
observ
mice
inject
poli
c
hayashi
et
al
current
data
suggest
stimul
downregul
pancreat
function
protect
mechan
limit
extent
tissu
damag
promot
transit
inflammatori
process
stage
tissu
regener
mechan
also
play
import
role
hepat
gener
inflammatori
syndrom
demonstr
pharmacolog
induct
kinas
aim
preemptiv
acceler
downregul
reduc
sever
inflammatori
tissu
injuri
may
prove
use
treatment
acut
inflammatori
condit
delin
role
ifn
pancreat
use
clinic
relev
model
involv
inject
caerulein
peptid
mimic
effect
cholecystokinin
induc
key
pathogenet
element
acut
pancreat
includ
pancreat
duct
obstruct
prematur
activ
trypsin
pandol
reichert
et
al
caerulein
inject
trigger
elev
plasma
level
ifnb
supplementari
fig
pancreat
mrna
level
ifnstimul
gene
supplementari
fig
furthermor
treatment
led
notic
increas
level
amylas
blood
plasma
fig
characterist
histopatholog
alter
pancrea
primari
pancreat
tissu
autodigest
injuri
manifest
loss
acinar
cell
evid
secondari
inflamm
includ
activ
kinas
tissu
edema
immun
cell
infiltr
remark
wild
type
mice
display
similar
sever
alter
fig
supplementari
fig
suggest
either
ifn
signal
play
role
pathogenesi
acut
pancreat
inactiv
condit
wild
type
tissu
level
protein
pancrea
inde
decreas
caerulein
treatment
fig
given
trypsin
activ
inflam
pancrea
cleav
extracellular
domain
vitro
supplementari
fig
divers
inflammatori
stimuli
induc
ubiquitin
intracellular
domain
lead
endocytosi
degrad
cultur
mammalian
cell
zheng
et
al
huangfu
et
al
plausibl
similar
proteolyt
inactiv
could
occur
vivo
inde
observ
induct
pancreat
robustli
increas
plasma
concentr
sever
inflammatori
cytokin
includ
vegf
tnfa
well
stimul
kinas
activ
pancreat
tissu
fig
furthermor
analysi
lysat
pancreat
tissu
wild
type
mice
reveal
increas
ubiquitin
respons
caerulein
inject
fig
given
data
plausibl
role
ifn
pathogenesi
pancreat
mask
rapid
elimin
protein
wild
type
anim
test
possibl
took
advantag
fact
numer
pathway
lead
ubiquitin
respons
inflammatori
stimuli
converg
phosphoryl
enabl
recruit
btrcp
ligas
fuch
previous
develop
knockin
mice
harbor
singl
allel
liu
et
al
zheng
et
al
tissu
anim
express
mutant
protein
resist
ubiquitin
induc
vegf
lp
vitro
zheng
et
al
use
anim
homozyg
mutant
allel
sa
mice
importantli
sa
mice
develop
normal
exhibit
neither
sign
growth
retard
gross
abnorm
supplementari
fig
hallmark
constitut
pancreat
inflamm
fig
c
cell
anim
exhibit
slower
rate
degrad
yet
display
hyperreact
ifn
signal
evid
lack
constitut
activ
supplementari
fig
sustain
abil
hematopoiet
cell
engraft
reconstitut
bone
marrow
lethal
irradi
mice
materi
method
experi
describ
normal
blood
cell
count
serum
chemistri
profil
well
mitochondri
activ
peripher
tissu
similar
wild
type
mice
supplement
tabl
howev
condit
experiment
pancreat
sa
mice
exhibit
notic
higher
pancreat
tissu
level
ifnstimul
protein
pkr
fig
ifnstimul
gene
supplementari
fig
compar
wild
type
anim
consist
key
role
subsequ
ifn
induct
platania
uze
et
al
stark
darnel
level
ifnb
plasma
caeruleintr
sa
mice
also
elev
supplementari
fig
importantli
mutant
receptor
remain
sensit
proteolyt
effect
extracellular
trypsin
vitro
supplementari
fig
observ
ubiquitin
downregul
respons
caeruleininduc
pancreat
vivo
fig
result
demonstr
analysi
inflamm
sa
mice
provid
us
tool
differenti
ubiquitinationdepend
independ
mechan
determin
whether
induct
ubiquitin
downregul
common
divers
inflammatori
condit
util
lp
treatment
stimul
gener
inflamm
vivo
inject
lp
decreas
cell
surfac
protein
experiment
pancreat
induc
inject
caerulein
assess
amylas
activ
level
plasma
indic
mice
indic
time
point
p
compar
b
h
e
stain
pancreata
obtain
mice
indic
time
caerulein
inject
black
blue
arrow
point
region
acinar
degener
leukocyt
infiltr
respect
size
bar
thereaft
lm
addit
pictur
anim
similar
greater
magnif
well
quantif
acinar
tissu
loss
shown
supplementari
fig
c
ihc
analysi
activ
kinas
pancreata
panel
b
immunoblot
analys
immunoprecipit
whole
pancreat
tissu
lysat
indic
mice
harvest
day
caerulein
salin
inject
carri
use
indic
antibodi
analys
activ
kinas
well
pkr
protein
whole
tissu
lysat
wtl
also
shown
total
level
kinas
depict
load
control
sourc
data
avail
figur
elimin
ifn
receptor
limit
inflammatori
damag
sabyasachi
bhattacharya
et
al
level
leukocyt
wild
type
sa
mice
fig
given
mrna
level
dramat
affect
fig
result
suggest
either
inflammationinduc
downregul
vivo
ubiquitinationdepend
sa
mice
effici
produc
inflammatori
cytokin
ifn
respons
lp
contrari
latter
hypothesi
much
higher
level
tnfa
ifnb
detect
plasma
sa
wild
type
anim
treat
lp
fig
supplementari
fig
data
collect
indic
promot
ubiquitin
import
downregul
receptor
respons
local
system
inflammatori
stimuli
vivo
remark
context
acut
pancreat
inflamm
sa
mice
exhibit
increas
amylas
level
compar
wild
type
anim
fig
greater
sever
pancreat
mice
also
manifest
extens
acinar
cell
loss
pronounc
leukocyt
infiltr
robust
activ
kinas
fig
togeth
greater
express
ifnstimul
gene
mrna
protein
supplementari
fig
fig
result
indic
stimul
ubiquitin
attenu
ifn
signal
may
protect
function
curb
pancreat
inflamm
also
argu
ifn
signal
play
import
role
develop
acut
pancreat
next
aim
investig
mechan
inflammationstimul
ubiquitin
may
contribut
protect
pancreat
tissu
excess
injuri
first
focus
balanc
inflammatori
cytokin
eg
tnfa
antiinflammatori
cytokin
eg
notic
higher
tnfa
mrna
level
found
pancreat
tissu
sa
mice
wild
type
counterpart
fig
addit
pancreatitisinduc
increas
blood
plasma
tnfa
level
also
greater
sa
fold
mice
level
protein
blood
plasma
higher
caeruleintr
sa
anim
ae
versu
ae
pgml
wild
type
mice
indic
system
antiinflammatori
respons
consist
report
increas
cytokin
caeruleintr
mice
zhou
et
al
document
abil
ifn
induc
product
leukocyt
vitro
aman
et
al
rudick
et
al
howev
unexpectedli
low
mrna
level
found
pancreat
tissu
sa
anim
fig
result
suggest
downregul
cell
local
focu
inflamm
restrain
product
inflammatori
tnfa
promot
express
antiinflammatori
given
inflammatori
cytokin
pancrea
produc
infiltr
leukocyt
assess
recruit
cell
inflam
tissu
wild
type
sa
mice
upon
caerulein
inject
pancreata
sa
anim
display
greater
extent
infiltr
leukocyt
seen
histolog
analysi
fig
supplementari
fig
immunofluoresc
analysi
cell
fig
among
leukocyt
myeloid
cell
display
promin
prefer
diffus
pancreat
infiltr
sa
mice
fig
control
stain
supplementari
fig
addit
cell
repres
major
leukocyt
highli
infiltr
area
mice
supplementari
fig
pancreata
mice
also
exhibit
low
express
mrna
chemotact
cell
fig
accordingli
notic
fewer
cell
fig
convers
robust
increas
express
monocyteattract
chemokin
rel
low
level
neutrophil
chemoattract
fig
consist
predomin
pancreat
infiltr
monocytesmatur
macrophag
low
sa
mice
fig
supplementari
fig
care
analysi
kinet
acut
pancreat
wild
type
mice
show
tissu
damag
peak
day
caerulein
inject
wherea
pancreat
gland
collect
day
show
sign
subsid
inflamm
reestablish
tissu
integr
yet
pancreata
sa
mice
exhibit
sing
acinar
cell
restor
display
persist
immun
infiltr
fig
supplementari
fig
even
greater
increas
pancreat
inflamm
damag
observ
sa
mice
receiv
multipl
inject
caerulein
model
chronic
pancreatit
fig
supplementari
fig
unlik
wild
type
mice
display
sign
inflamm
includ
edema
leukocyt
infiltr
restor
tissu
fig
pancreata
sa
anim
remain
highli
inflam
fig
supplementari
fig
exhibit
pronounc
sign
tissu
damag
degener
fibrosi
fig
data
strongli
suggest
induct
ubiquitin
restrict
extent
inflamm
tissu
injuri
enabl
pancreat
tissu
regener
chronic
pancreat
fac
analysi
cell
surfac
level
peripher
blood
leukocyt
pbl
periton
leukocyt
pl
indic
mice
harvest
h
inject
either
salin
sal
red
lp
blue
ig
antibodi
isotyp
control
gray
b
analysi
rel
mrna
level
pbl
treat
panel
n
group
c
elisa
analys
level
indic
cytokin
ngml
blood
plasma
indic
mice
n
genotyp
treat
salin
lp
h
nd
level
pgml
autoimmun
toxic
hepat
exacerb
ineffici
ubiquitin
sought
examin
whether
ubiquitinmedi
downregul
could
import
limit
damag
inflam
tissu
end
util
two
independ
model
experiment
hepat
induc
either
concanavalin
cona
trigger
autoimmun
hepat
tieg
et
al
carbon
tetrachlorid
ccl
caus
hepat
necrosi
reactiv
hepat
luster
et
al
remark
model
observ
robust
induct
ubiquitin
downregul
protein
mrna
liver
tissu
wild
type
sa
mice
fig
supplementari
fig
convers
latter
anim
exhibit
notic
higher
express
pkr
protein
fig
express
tnfa
mrna
supplementari
fig
level
plasma
ifnb
supplementari
fig
data
shown
parallel
sever
hepat
inflamm
promin
greater
sa
mice
compar
wild
type
anim
judg
increas
releas
liver
aminotransferas
hepatocyt
bloodstream
serum
ast
alt
fig
furthermor
liver
harvest
sa
mice
exhibit
dramat
histopatholog
alter
fig
supplementari
fig
along
robust
activ
kinas
fig
greater
number
hepat
lesion
consist
higher
hepat
grade
tabl
alter
sa
mice
togeth
pronounc
leukocyt
infiltr
supplementari
fig
strongli
suggest
ubiquitin
play
protect
role
hepat
either
autoimmun
toxic
etiolog
collect
data
implic
ubiquitin
degrad
import
common
mechan
limit
extent
inflammatori
liver
injuri
within
foci
inflamm
acceler
ubiquitindepend
turnov
may
occur
divers
type
cell
includ
figur
aberr
cytokin
balanc
inflammatori
monocyt
recruit
inflam
pancreat
tissu
sa
mice
fold
induct
mrna
tnfa
normal
per
bactin
mrna
pancreata
indic
mice
n
genotyp
harvest
day
caerulein
inject
normal
mrna
level
mice
receiv
salin
assign
valu
p
comparison
wild
type
mice
b
immunofluoresc
analysi
pancreata
indic
mice
harvest
day
caerulein
inject
carri
frozen
section
use
antibodi
c
immunofluoresc
analysi
indic
pancreata
process
b
use
indic
antibodi
posit
neg
control
specif
antibodi
shown
supplementari
fig
immunofluoresc
coloc
analysi
indic
pancreata
process
describ
b
parenchym
endotheli
stromal
cell
well
immun
cell
recruit
target
organ
differenti
role
ubiquitin
hematopoieticimmun
compart
versu
peripher
tissu
bone
marrow
transfer
bmt
approach
util
initi
compar
sever
acut
pancreat
sa
anim
receiv
bmt
either
mice
genotyp
wild
type
anim
latter
chimer
mice
challeng
caerulein
exhibit
lesser
increas
level
serum
amylas
activ
fig
blue
bar
v
red
bar
convers
replac
bone
marrow
wild
type
mice
sa
anim
augment
induct
serum
amylas
fig
white
bar
v
black
bar
data
corrobor
histopatholog
analys
fig
supplementari
fig
demonstr
sever
pancreat
correl
express
ubiquitinationdefici
sa
mutant
bone
marrowderiv
cell
peripher
tissu
import
ubiquitin
within
central
immun
compart
tissu
protect
next
investig
hepat
model
induc
ccl
chimer
anim
receiv
bmt
wild
type
mice
consist
exhibit
lesser
serum
level
liver
aminotransferas
fig
fewer
hepat
lesion
overal
lower
hepat
score
fig
supplementari
fig
tabl
hand
experi
use
revers
approach
bmt
sa
anim
wild
type
mice
reveal
robustli
augment
liver
tissu
damag
inflammatori
phenotyp
fig
supplementari
fig
tabl
data
indic
ubiquitin
degrad
bone
marrowderiv
cell
recruit
foci
inflamm
play
common
major
tissu
protect
role
downregul
byproduct
inflamm
limit
tissu
injuri
preemptiv
pharmacolog
elimin
receptor
might
use
tissu
protect
approach
agent
trigger
elimin
theoret
capabl
induc
serin
phosphoryl
subsequ
ubiquitin
endogen
lipid
mediat
lysophosphatid
acid
lpa
previous
shown
act
immun
cell
graler
goetzl
activ
kinas
chiu
et
al
thu
test
effect
lpa
ubiquitin
relat
inflammatori
condit
end
vivo
signal
experi
util
intraven
inject
mice
lpa
follow
analysi
splenic
tissu
use
lpa
treatment
induc
phosphoryl
wild
type
mice
fig
expect
effect
seen
sa
anim
whose
receptor
contain
alanin
residu
posit
importantli
wild
type
sa
tissu
exhibit
increas
ubiquitin
fig
furthermor
inject
wild
type
mice
lpa
led
amylas
activ
serum
indic
mice
inject
caerulein
lgkg
day
week
indic
amount
week
b
h
e
stain
pancreata
mice
receiv
inject
salin
caerulein
week
describ
panel
arrow
point
area
restor
tissu
white
chronic
tissu
damag
manifest
continu
edema
black
fibrot
tissu
replac
acinar
epithelium
blue
c
acinar
tissu
damag
indic
pancreata
mice
describ
panel
b
quantifi
acinar
tissu
loss
compar
salinetr
anim
p
h
e
stain
pancreata
indic
caeruleintr
mice
treat
panel
b
depict
differ
magnif
highlight
tissu
degener
leukocyt
infiltr
arrow
indic
area
describ
panel
b
notic
downregul
protein
mrna
splenocyt
fig
attenu
sensit
cell
ifn
vitro
assess
ifninduc
activ
fig
importantli
neither
event
observ
sa
tissu
fig
c
data
indic
lpa
util
trigger
ubiquitin
degrad
immunoblot
analys
immunoprecipit
liver
lysat
indic
mice
harvest
h
treatment
cona
salin
control
h
treatment
ccl
oil
control
carri
use
indic
antibodi
analys
activ
kinas
well
pkr
protein
whole
tissu
lysat
wtl
also
shown
total
level
kinas
depict
load
control
b
activ
alanin
alt
aspart
ast
aminotransferas
blood
plasma
wild
type
sa
mice
n
group
treat
indic
p
compar
wild
type
c
h
e
stain
liver
tissu
mice
describ
panel
b
arrow
point
hepat
lesion
concurr
area
leukocyt
infiltr
ihc
analysi
activ
kinas
liver
tissu
panel
c
sourc
data
avail
figur
elimin
ifn
receptor
limit
inflammatori
damag
sabyasachi
bhattacharya
et
al
attenu
ifn
signal
vivo
moreov
sa
mice
defici
ubiquitin
yet
compet
lpainduc
activ
kinas
fig
serv
critic
control
allow
distinguish
role
lpainduc
elimin
pleiotrop
effect
lpa
test
effect
lpa
clinic
relev
model
toxic
hepat
induc
analges
agent
acetaminophen
apap
whose
overdos
caus
sever
liver
damag
greatli
contribut
acut
liver
failur
nonvir
etiolog
human
patient
ostapowicz
lee
bernal
et
al
greater
extent
apapinduc
liver
damag
assess
plasma
aminotransferas
level
detect
sa
mice
compar
wild
type
anim
astalt
level
apaptr
wild
type
significantli
decreas
upon
treatment
lpa
observ
effect
sa
mice
fig
supplementari
fig
given
latter
mice
express
receptor
whose
ubiquitin
level
affect
lpa
fig
b
result
specif
suggest
lpainduc
ubiquitin
degrad
protect
hepat
tissu
toxic
injuri
determin
benefit
target
inflamm
use
neutral
antibodi
bind
extracellular
domain
sheehan
et
al
therefor
block
signal
wild
type
ubiquitinationdefici
receptor
inde
inject
antibodi
notic
decreas
apapinduc
hepat
anim
fig
supplementari
fig
furthermor
similar
result
either
lpa
antibodi
obtain
hepatotox
induc
use
ccl
supplementari
fig
collect
result
suggest
target
via
either
block
extracellular
domain
antibodi
induc
ubiquitin
intracellular
domain
lpalik
agent
use
protect
liver
excess
inflammatori
damag
intriguingli
abil
lpa
moder
gener
inflamm
induc
lp
previous
report
although
mechan
underli
effect
yet
understood
fan
et
al
zhao
et
al
toxic
lp
attenu
upon
genet
ablat
karaghiosoff
et
al
remain
unclear
whether
induct
ubiquitin
wild
type
anim
might
function
mechan
reduc
lp
toxic
orand
target
protect
effect
lpa
conduct
experi
lpsinduc
cytokin
fig
unabl
compar
level
cytokin
wild
type
sa
mice
past
h
lp
treatment
earli
lethal
sa
group
lethal
like
associ
strikingli
greater
extent
lung
injuri
includ
pronounc
leukocyt
infiltr
interstiti
alveolar
space
edema
alveolar
distort
observ
within
h
lp
inject
fig
remark
detail
analysi
surviv
reveal
signific
amylas
activ
level
serum
chimer
mice
indic
bone
marrow
transplant
donor
recipi
n
group
follow
caerulein
inject
p
sa
sa
b
h
e
stain
pancreata
obtain
chimer
mice
describ
panel
c
activ
alanin
alt
aspart
ast
aminotransferas
serum
chimer
mice
indic
bone
marrow
transplant
donor
recipi
n
group
inject
ccl
oil
vehicl
control
p
h
e
stain
liver
tissu
mice
describ
panel
c
protect
effect
lpa
treatment
wild
type
sa
mice
fig
result
indic
ubiquitin
intrins
mechan
play
critic
role
prevent
fulmin
cours
lpsinduc
septic
shock
furthermor
collect
data
provid
proof
principl
pharmacolog
stimul
ubiquitin
effect
strategi
acut
local
gener
inflammatori
syndrom
data
present
indic
stimul
ubiquitin
degrad
bone
marrowderiv
cell
recruit
foci
inflamm
play
major
protect
role
inflamm
strike
system
local
phenotyp
observ
sa
mice
etiolog
pathogenet
divers
type
immunoblot
analys
immunoprecipit
whole
tissu
lysat
wtl
spleen
mice
inject
lpa
mgkg
min
prior
harvest
carri
use
indic
antibodi
b
fac
analysi
cell
surfac
level
splenocyt
indic
mice
harvest
h
treatment
either
salin
lpa
lgml
right
panel
depict
rel
mrna
level
analyz
condit
n
group
c
immunoblot
analysi
phosphoryl
level
splenocyt
sa
mice
treat
h
either
salin
lpa
lgml
isol
treat
vitro
ifnb
uml
min
indic
ast
activ
plasma
sa
mice
collect
h
inject
acetaminophen
apap
mgkg
ip
indic
mice
also
inject
lpa
iv
mgkg
n
mice
treatment
control
group
neutral
antibodi
iv
lg
n
mice
treatment
control
group
h
apap
treatment
e
h
e
stain
lung
indic
mice
treat
salin
lp
h
f
kaplanmei
analysi
surviv
indic
mice
treat
lp
mgkg
without
lpa
mgkg
sourc
data
avail
figur
elimin
ifn
receptor
limit
inflammatori
damag
sabyasachi
bhattacharya
et
al
inflammatori
syndrom
illustr
two
import
point
first
result
suggest
acceler
ubiquitin
ensu
downregul
respons
numer
stimuli
may
least
extent
function
mimic
complet
loss
receptor
via
genet
ablat
specif
physiolog
patholog
scenario
acceler
degrad
may
result
phenotyp
equival
wild
type
knockout
anim
equival
overinterpret
lack
role
ifn
given
physiolog
process
patholog
condit
second
given
upregul
seen
sa
mice
contribut
increas
ligand
product
supplementari
fig
inabl
elimin
may
creat
feedforward
signal
amplif
mechan
importantli
augment
ifn
signal
well
phenotyp
observ
sa
mice
evid
despit
numer
neg
regul
ifn
pathway
function
downstream
receptor
includ
express
signal
transcript
inhibitor
includ
tyrosin
phosphatas
suppressor
cytokin
signal
sprouti
protein
inhibitor
stat
etc
coccia
et
al
zhang
zhang
sharma
et
al
fact
suggest
ubiquitinationdepend
downregul
repres
major
critic
import
mechan
attenu
sensit
cell
tissu
ifn
play
key
role
limit
ifnmedi
immunopatholog
mechan
elimin
cell
within
inflam
tissu
aid
restrict
tissu
damag
switch
recoveri
like
complex
temporarili
limit
output
ifn
signal
expect
attenu
direct
detriment
effect
ifn
cell
growth
viabil
affect
ifninduc
katsoulidi
et
al
nfjbregul
du
et
al
inflammatori
pathway
known
contribut
express
addit
inflammatori
cytokin
karin
furthermor
previous
publish
studi
show
express
essenti
effici
signal
mitani
et
al
produc
cytokineschemokin
either
directli
kill
cell
contribut
subsequ
wave
recruit
immun
cell
capabl
damag
inflam
tissu
pancreat
inflamm
mice
defici
ubiquitin
parallel
alter
balanc
proinflammatori
antiinflammatori
cytokin
eg
tnfa
increas
express
fig
given
ifn
directli
induc
transcript
buttmann
et
al
mediat
recruit
inflammatori
monocyt
turn
produc
tnfa
inflammatori
cytokin
guha
mackman
plausibl
downregul
may
help
restrict
pathway
consist
possibl
greater
number
inflammatori
monocytesmacrophag
observ
tissu
sa
mice
fig
supplementari
fig
addit
dramat
defici
tissu
repair
regener
seen
chronic
pancreat
model
fig
supplementari
fig
suggest
mechan
affect
mesenchym
stem
cell
orand
endotheli
progenitor
might
involv
well
light
demonstr
resist
endotheli
cell
sa
mice
vegfinduc
angiogenesi
zheng
et
al
along
observ
elev
level
vegf
protect
tissu
injuri
human
patient
acut
pancreat
ueda
et
al
role
effici
ubiquitin
ensur
adequ
blood
suppli
regener
tissu
might
import
futur
studi
delin
mechan
elimin
aid
tissu
recoveri
warrant
practic
relev
mechan
util
elimin
attenu
respons
tissu
ifn
hepat
underscor
sever
clinic
observ
despit
use
ifn
treatment
chronic
viral
hepat
caus
hepat
c
b
virus
hepat
side
effect
includ
exacerb
liver
damag
ifn
administr
wide
report
dusheiko
propos
previous
intervent
aim
enabl
withstand
inflammatori
elimin
may
increas
efficaci
ifn
tumor
huangfu
et
al
current
result
argu
expand
clinic
consider
prevent
stimul
turnov
induct
order
limit
harm
effect
ifn
inde
treatment
lpa
capabl
induc
ubiquitin
protect
wild
type
sa
anim
toxic
hepat
fulmin
gener
inflamm
fig
data
provid
proof
principl
pharmacolog
downregul
use
acut
lifethreaten
inflammatori
condit
concern
attenu
antivir
antitumor
defens
secondari
similar
lpa
numer
natur
synthet
agonist
gprotein
coupl
receptor
capabl
activ
kinas
rosenbaum
et
al
tilley
agent
receptor
alreadi
shown
play
role
regul
sever
inflamm
ohta
sitkovski
use
receptor
agonist
may
help
fact
receptor
express
either
ubiquit
tissuespecif
manner
jacobi
et
al
therebi
afford
system
select
protect
effect
studi
describ
uncov
endogen
mechan
inflammatori
process
confin
harm
phase
enabl
transit
tissu
restor
promot
ubiquitin
degrad
addit
mimick
natur
mechan
preemptiv
induct
kinas
lead
stimul
ubiquitin
elicit
tissu
protect
effect
pharmacolog
stimul
ubiquitin
degrad
repres
fundament
novel
strategi
limit
extent
tissu
damag
acceler
heal
restor
function
given
modul
gprotein
coupl
receptor
compris
popul
class
current
avail
drug
rosenbaum
et
al
wang
lewi
valid
concept
practic
applic
elimin
acut
lifethreaten
inflammatori
syndrom
like
immin
detail
materi
method
see
supplementari
inform
institut
anim
care
use
committe
iacuc
univers
pennsylvania
approv
anim
procedur
diseas
model
blood
collect
euthanasia
tissu
harvest
protocol
eight
week
old
femal
litterm
mice
includ
wild
type
mice
sa
mice
zheng
et
al
liu
et
al
treat
cre
remov
neo
marker
vitro
wherea
cell
heterozyg
mice
sa
use
previou
public
zheng
et
al
current
experi
carri
use
animalscel
wild
type
allel
replac
homozyg
sa
mice
background
sa
gener
embryon
stem
cell
liu
et
al
maintain
background
mice
backcross
background
gener
homozyg
indic
allel
gener
inflamm
model
mice
treat
lp
mgkg
intraperiton
inject
sacrif
becam
moribund
display
loss
right
reflex
loss
bodi
weight
nonrespons
footpad
compress
previous
describ
karaghiosoff
et
al
bone
marrow
harvest
transfer
carri
describ
elsewher
pear
et
al
blood
cell
plasma
chemistri
analys
includ
astalt
assay
carri
clinic
patholog
laboratori
univers
pennsylvania
ryan
veterinari
hospit
experiment
pancreat
induc
previous
describ
reichert
rustgi
reichert
et
al
briefli
acut
pancreat
induc
hourli
intraperiton
inject
caerulein
lgkg
two
consecut
day
blood
collect
tail
vein
day
first
inject
point
mice
sacrif
pancreata
harvest
process
mrna
isol
either
frozen
sectionimmunohistochemistri
formalinfix
subsequ
hematoxylineosin
stain
amylas
assay
carri
per
manufactur
instruct
quantichrom
aamylas
assay
kit
chronic
pancreat
induc
inject
caerulein
lgkg
per
day
day
week
week
end
everi
week
day
blood
collect
tail
vein
mice
sacrif
week
pancreata
harvest
analyz
indic
induc
autoimmun
hepat
mice
inject
intraven
concanavalin
mgkg
vehicl
steril
salin
sacrif
h
later
blood
tissu
harvest
induc
toxic
hepat
mice
inject
intraperiton
ccl
mlkg
vehicl
oliv
oil
sacrif
h
altern
mice
inject
acetaminophen
apap
mgkg
ip
sacrif
h
blood
process
altast
analys
liver
either
flash
frozen
extract
mrna
fix
formalin
hematoxylin
eosin
stain
histopatholog
analys
carri
doubl
blind
manner
qualifi
veterinari
pathologist
ab
quantif
lesion
carri
count
number
lesion
per
field
averag
ten
field
per
mous
five
mice
per
group
score
assess
sever
hepat
done
evalu
tissu
scale
score
repres
grade
none
paper
explain
problem
inflamm
adapt
process
combin
counteract
element
tissu
destruct
versu
heal
limit
eventu
elimin
harm
effect
irrit
infecti
agent
initi
stage
inflamm
exacerb
tissu
damag
often
follow
subsequ
regenerationrepair
tissu
restor
function
failur
progress
later
stage
contribut
develop
mani
human
diseas
mechan
limit
tissu
injuri
promot
transit
restor
phase
poorli
understood
type
interferon
ifn
protect
organ
virus
tumor
yet
elicit
tissu
toxic
often
manifest
patient
tumor
chronic
viral
infect
treat
ifnbas
drug
effect
ifn
mediat
cell
surfac
receptor
whose
level
regul
phosphorylationdepend
ubiquitin
degrad
chain
importantli
process
depriv
cell
abil
respond
futur
encount
ifn
stimul
inflammatori
stimuli
vitro
regul
occur
vivo
would
pose
medic
problem
reduc
efficaci
pharmaceut
ifn
inflam
tissu
furthermor
exist
mechan
counterintuit
host
defens
may
limit
antivir
antitumorigen
benefit
endogen
produc
ifn
within
region
inflamm
henc
sought
investig
manifest
biolog
signific
inflammationinduc
ubiquitin
downregul
vivo
induct
pancreat
hepat
gener
inflamm
robustli
downregul
mice
downregul
seen
knockin
mice
incap
stimul
ubiquitin
importantli
mice
highli
suscept
acut
chronic
pancreat
toxic
autoimmun
hepat
bacteri
endotoxininduc
septic
shock
alter
balanc
proinflammatori
antiinflammatori
cytokin
specif
chemokin
result
recruit
inflammatori
monocyt
observ
pancreat
tissu
ubiquitinationdefici
mice
mice
display
extens
damag
persist
immun
infiltr
inflam
tissu
case
gener
inflamm
overwhelm
mortal
condit
chronic
pancreat
mice
also
exhibit
dramat
impair
abil
repair
pancreat
tissu
restor
anatom
function
integr
experi
use
bone
marrow
transplant
determin
inabl
ubiquitin
degrad
hematopoiet
compart
respons
excess
pancreat
hepat
inflammatori
phenotyp
importantli
pharmacolog
stimul
protein
kinas
stimul
ubiquitin
protect
toxic
hepat
fulmin
gener
inflamm
wild
type
ubiquitinationdefici
mice
studi
describ
uncov
endogen
mechan
inflammatori
process
confin
harm
phase
enabl
transit
tissu
restor
promot
ubiquitin
degrad
addit
mimick
natur
mechan
preemptiv
induct
protein
kinas
lead
stimul
ubiquitin
elicit
tissu
protect
effect
pharmacolog
stimul
ubiquitin
degrad
repres
fundament
novel
strategi
limit
extent
tissu
damag
acceler
heal
restor
function
furthermor
similar
strategi
could
potenti
use
temper
toxic
side
effect
ifnbas
drug
given
mani
current
avail
drug
potenti
capabl
stimul
ubiquitin
valid
concept
practic
applic
elimin
acut
lifethreaten
inflammatori
syndrom
like
immin
minim
inflamm
mild
hepat
moder
hepat
limit
necrot
foci
sever
hepat
includ
mark
necrosi
display
multifoc
coalesc
hepatocellular
hyperplasia
hypertrophi
vacuol
data
express
mean
ae
sd
standard
deviat
number
sampl
shown
figur
orand
figur
legend
experiment
cohort
statist
analys
perform
use
microsoft
excel
graphpad
prism
softwar
differ
determin
unpair
twotail
student
ttest
pvalu
consid
statist
signific
